The Mumbai-based drug maker said the agreement strengthens the company's diabetes portfolio and accelerates its presence in the obesity segment.
Lupin Signs Licensing, Supply And Distribution Deal With Chinese Firm For Obesity Drug
Published 2 hours ago
Source: feeds.feedburner.com
Categories
Business
Related Articles from feeds.feedburner.com
59 minutes ago
BMC Elections 2026: Ajit Pawar's NCP Releases Second List Of 27 Candidates For Mumbai Civic Polls
1 hour ago
Hubble's New Data Reveals Twin Jets From Interstellar Comet 3I/ATLAS
1 hour ago
Red Alert In Delhi Over Dense Fog, Air Quality Returns To "Severe"
1 hour ago
Centre To Borrow Rs 3.84 Lakh Crore Via Short-Term Treasury Bills In Q4
1 hour ago
Govt Grants One-Year Exemption On Quality Norms For Select Imported Copper Products
1 hour ago